Abstract
A S L D A b st ra ct s insufficiency in 2 and liver abscess in 3 patients). A post-embolization syndrome was seen in 14%. None of the patients developed liver failure after TACE. Our study shows that TACE is an efficacious and safe therapeutic modality for HCC patients unsuitable for surgical therapy. Tumor stage, degree of liver disease, response to TACE and patients' age were independent risk factors for patient survival.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
